28 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
to serve as Executive Chair of the Board of Directors;
Appointed medical technology expert Dr. John DeFord to the Board of Directors;
Took occupancy
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
associated with that role. Dr. DeFord, a medical technology expert, was appointed to fill the vacancy.
Dr. DeFord is the Chairman, Chief Executive Officer
8-K
EX-10.2
o001xvuf33n cmf
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-3.2
60l8i0d5l
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.3
kqjnir 41f
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
cimpn0uhho a34dx6kj
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
linbe9m9o4hr lij73
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-10.8
i2p9zqz9wea
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.12
my0 dqi97
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.9
n36zuvsia46m3luh7
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.10
okrz0nwx0wru rxq9dn2
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-3.2
79t61i3hsg yi133yg
9 Nov 20
IPO registration (amended)
2:05pm
S-1
EX-10.20
vm5313xz7oss8mht54
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.23
7dae9 6ka
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.21
h2l hh65e
29 Oct 20
IPO registration
5:04pm
S-1
z4r6go
29 Oct 20
IPO registration
5:04pm